PharmaSim
Ethan Melvin
Jared Houtman
Marcos Lucero
Andrew Miera
Marketing Plan
Highlights The 4 P’s
Initial Objectives
Determine the Most
Appropriate Target
Market For Each
Product.
Focus Advertising on
Benefits Rather Than
Comparison
Be Perceived as a High
End Product For a
Reasonable Price
Become a Leading
Competitor In the Cold,
Cough, and Allergy
Markets
Solidify Market Share
Through Rounds 1 and 2
Key Success
Factors in
Pharmasim
Cumulative
Manufacturer
Sales
Comparison
Round 1 > Round 2
- No Real Change
- Pricing
Cumulative
Net Income
Comparison
Round 2 > Round 1
- Higher Prices
- Lower Volume Discounts
Share of Retail
Sales %
Comparison
Round 1 > Round 2
- Advertising Message was
flipped
5% : Primary , Reminder
45% : Benefits , Comparison
- Start of Period 4
Advertising Message Adjusted
Stock Price
Comparison
Round 1 > Round 2
- Similar Start
- Period 3
- Recovery
- Period 7
- Lower Result
- Period 9
- Distribution of Budget
- Price & COGS Increase
Performance
Cons
- Constantly Chasing Price
- Budget Allocation
- Period 9
- Round 2
Pros
- Evaluations of Target Market
- Allright Maintenance
- Allright Product
- We Tried
Future Position
Of Company
- In terms of shareholders;
A great time to buy Allstar stock at such a
low price!!
- Room for Growth
- Brand Reconstruction
- Pricing Alignment
Takeaways From Pharmasim
● Pricing can be very difficult to get right and hard to recover if
you are too low
● Understanding your brand situation/position with the right
balance between promotions and advertising is key
● Understand what competitors are doing to stay relevant.
● It is equally important to understand both the needs of our
retailers and the desires of individual customers.
● WIth more available decisions, the more careful you have to be
● KNOW WHERE YOU ARE EACH PERIOD
? ??
?
?
?

Pharma sim strategy

Editor's Notes

  • #3 -Allround was never reformulated -Price in Round 1 was dropped at first then was raised over time -Price in Round 2 was increased at start then and steadily grew -Place - Direct (retail) - Indirect (pharmacists) -Allowance would stay around 16%-18%
  • #5 Target Market - RD1 - Young Families & Mature Families RD 2 - ++ Young Singles & Retired Sales Force - RD2 > RD1
  • #11 - In the eyes of shareholders, the position of Allstar is at point where it is wise to purchase stock. -There is certainly room for growth as well as opportunities for brand reconstruction and pricing alignment - The price for Allright will need be adjusted in order for increased sales and consumer attitude towards the product.